MA
58
3
HP
33
4
VMC
65
2
BDX
49
-5
EXR
55
5
ZTS
47
-16
BSX
71
2
AN
60
2
SYK
42
-13
EMC
89
15
DD
67
11
IVZ
43
5
MTCH
55
5
SEE
57
2
BWA
64
3
HPQ
67
4
ICE
62
7
GOOGL
74
2
USB
44
5
CAH
40
-3
MA
58
3
HP
33
4
VMC
65
2
BDX
49
-5
EXR
55
5
ZTS
47
-16
BSX
71
2
AN
60
2
SYK
42
-13
EMC
89
15
DD
67
11
IVZ
43
5
MTCH
55
5
SEE
57
2
BWA
64
3
HPQ
67
4
ICE
62
7
GOOGL
74
2
USB
44
5
CAH
40
-3
Financhill
Back

Rocket Lab USA 10K Form

Buy
63

RKLB
Rocket Lab USA

Last Price:
4.00
Seasonality Move:
13.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKLB News And Ratings

See the #1 stock for the next 7 days that we like better than RKLB

RKLB Financial Statistics

Sales & Book Value

Annual Sales: $244.59M
Cash Flow: $-52.63M
Price / Cash Flow: 0
Annual Sales: $1.13
Price / Book: 3.53

Profitability

EPS (TTM): -0.38000
Net Income (TTM): $-182.57M
Gross Margin: $51.41M
Return on Equity: -29.79%
Return on Assets: -18.81%

Rocket Lab USA Earnings Forecast

Key Rocket Lab USA Financial Ratios

  • The Gross Profit Margin over the past 4 years for RKLB is 21.02%.
  • The Selling, General & Administrative Expenses for RKLB have been equal to 45.08% of Gross Profit Margin.
  • The Research & Development expenses have been 48.67% of Revenue.
  • The Interest Expense is -5.74% of Operating Income.
  • The Net Earning history of RKLB is -74.64% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Rocket Lab USA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: RKLB
Website: rocketlabusa.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 2.13
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RKLB Technical Analysis vs Fundamental Analysis

Buy
63
Rocket Lab USA (RKLB) is a Buy

Is Rocket Lab USA a Buy or a Sell?

  • Rocket Lab USA stock is rated a Buy
    The current Rocket Lab USA [RKLB] share price is $4.00. The Score for RKLB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.